New Shubatine 20mg (Rosuvastatin Calcium)
Rosuvastatin Calcium
Prescription medication
Anguk New Pharm Co., Ltd.
MFDS item code 201802675 · Approved 2018.06.27
This product's status changed to Expired on 2023.06.27. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease
This medicine is used as an adjunct in cases of primary hypercholesterolemia, heterozygous familial hypercholesterolemia, and combined hyperlipidemia where diet and exercise alone are insufficient to control levels. It is also used in combination with other treatments for patients with homozygous familial hypercholesterolemia to enhance effectiveness. It lowers total cholesterol and LDL cholesterol levels, slows the progression of atherosclerosis, and helps improve hypercholesterolemic conditions in some pediatric patients. It is also used as an adjunct to dietary measures for patients with primary dysbetalipoproteinemia. Furthermore, it contributes to a decrease in the risk of stroke, myocardial infarction, and arterial revascularization procedures in patients at high risk for cardiovascular disease. This medicine effectively improves hyperlipidemia and the risk of cardiovascular diseases.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is sufficient for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 milligrams daily. 3. Older adults : No dose adjustment is necessary. 4. Patients with renal impairment : No dose adjustment is necessary in patients with mild to moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment : No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race : Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy : The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.
2. Pediatric patients with heterozygous familial hypercholesterolemia (aged 10 to 17 years) The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses greater than 20 milligrams in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Safety and efficacy have not been established in children under 10 years of age.
This medication should not be used in certain patients. For example, individuals allergic to any components of this drug, those with severe liver dysfunction, individuals with muscle disorders, and women who are pregnant or breastfeeding should not take this drug. This medication can affect liver health; thus, individuals with a history of liver disease or those who consume alcohol excessively should undergo regular liver function tests before and during treatment. Patients with specific conditions such as hypothyroidism or nephrotic syndrome should treat those conditions prior to taking this medication. Muscle-related symptoms may occur, so if symptoms such as myalgia, muscle weakness, or cramps arise, immediate consultation with a doctor is necessary. Caution is especially required in the elderly, those with impaired kidney function, or individuals who abuse alcohol, as they have a higher risk of muscle adverse reactions. This medication can interact with other drugs, increasing blood concentration and the risk of side effects; therefore, it is essential to consult a doctor or pharmacist when taking other medications, especially certain antivirals, immunosuppressants, antifungals, some antibiotics, and fibrate-class medications. Women of childbearing age should use appropriate contraception while taking this drug, and if pregnancy occurs, they must stop taking it immediately. Additionally, this medication may be excreted in breast milk, so it's advisable not to use it while breastfeeding. In the case of overdose, there is no specific antidote; hence, treatment according to symptoms and tests for liver and muscle function may be required. Finally, dizziness may occur during the usage of this drug, so caution should be exercised when driving or operating machinery. It is important to consult medical personnel immediately if abnormal reactions occur during the use of this drug.
Angioedema, hypersensitivity reaction, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, cough, dyspnea, diarrhea, thrombocytopenia, jaundice, hepatitis, increased transaminase, Stevens-Johnson syndrome, eosinophilia, drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, increased AST, joint pain, fatigue, numbness, sensory abnormalities, chest discomfort, loss of appetite, abdominal distension, abnormal liver function tests, syncope, generalized pain
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air and moisture from entering and kept in a cool place below 30 degrees Celsius. Proper storage can help maintain effectiveness over time and prevent deterioration.
Pink round film-coated tablet
30 tablets (10 tablets/Alu-Alu x 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Rosuvastatin Calcium
Prescription medication
Anguk New Pharm Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.